Browsing by Author George, Jacob

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 251 < previous   next >
Issue DateTitleAuthor(s)Citation
2010Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance.Fragomeli, Vincenzo; George, Jacob; van der Poorten, David; Weltman, Martin; Chisholm, Donald J; Dore, Gregory; Jenkins, Arthur; Milner, Kerry-Lee; Smythe, George A.; Trenell, Michael; Xu, Aimin; Zekry, Amany; Faculty of Nursing & Midwifery; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineChronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance., Gastroenterology, vol.138, 3,pp 932-941
2013Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLDGeorge, Jacob; Hebbard, Lionel; Baldelli, Enrica; Carulli, Lucia; Loria, Paola; Maurantonio, Mauro; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResClassical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD, Current Pharmaceutical Design, vol.19, 29, 2013,pp 5280-5296
2013Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLDGeorge, Jacob; Hebbard, Lionel; Baldelli, Enrica; Carulli, Lucia; Loria, Paola; Maurantonio, Mauro; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResClassical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD, Current Pharmaceutical Design, vol.19, 29, 2013,pp 5280-5296
2013Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLDGeorge, Jacob; Hebbard, Lionel; Baldelli, Enrica; Carulli, Lucia; Loria, Paola; Maurantonio, Mauro; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResClassical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD, Current Pharmaceutical Design, vol.19, 29, 2013,pp 5280-5296
2013Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLDGeorge, Jacob; Hebbard, Lionel; Baldelli, Enrica; Carulli, Lucia; Loria, Paola; Maurantonio, Mauro; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResClassical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD, Current Pharmaceutical Design, vol.19, 29, 2013,pp 5280-5296
2013Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLDGeorge, Jacob; Hebbard, Lionel; Baldelli, Enrica; Carulli, Lucia; Loria, Paola; Maurantonio, Mauro; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResClassical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD, Current Pharmaceutical Design, vol.19, 29, 2013,pp 5280-5296
2008Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver diseaseGeorge, Jacob; Poustchi, Hossein; Ayres, A; Bowden, Stephen A; Farrell, Geoffrey C.; Locarnini, S; Malekzadeh, R; Mohamadkhani, A; Montazeri, G; Revill, P; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease, Journal of Viral Hepatitis, vol.15,(10),2008,pp 753-760
2014Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran ​Esmaili, Saeed; George, Jacob; Besharat, Sima; et al, Various; Katoonizadeh, Aezam; Merat, Shahin; Mohamadkhani, A; Moossavi, Shirin; Ostovaneh, Mohammad Reza; Pourshams, Akram; Poustchi, Hossein; Sharafkhah, Maryam; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteCohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran ​, Middle East Journal of Digestive Diseases, vol.6, 4, 2014,pp 186-194
2012Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infectionBooth, David; George, Jacob; Stewart, Graeme; Suppiah, Vijayaprakash; Berg, Thomas; Bohm, Stephan; Bommel, Florian van; Brodzinski, Annika; Fischer, Janett; Fulop, Balazs; Migaud, Pascal; Muller, Tobias; Sarrazin, Christoph; Scholz, Markus; Schott, Eckart; Susser, Simone; Witt, Heiko; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteCombined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection, Hepatology, vol.55, 6, 2012,pp 1700-1710
2014Community-based hepatitis B screening: what works?George, Jacob; Robotin, Monica; Western Clinical School: Westmead Millennium Institute; School of Public Health: Public HealthCommunity-based hepatitis B screening: what works?, Hepatology International, vol.8, 4, 2014,pp 478-492
2014Community-based prevention of hepatitis-B-related liver cancer: Australian insightsGeorge, Jacob; Robotin, Monica; Kansil, Melanie Q.; Penman, Andrew; Porwal, Mamta; Western Clinical School: Westmead Millennium Institute; School of Public Health: Public HealthCommunity-based prevention of hepatitis-B-related liver cancer: Australian insights, Bulletin of the World Health Organization, vol.92, 5, 2014,pp 374-379
2012Comparison of noninvasive models of fibrosis in chronic hepatitis BGeorge, Jacob; McLeod, Duncan; Bourliere, M; Bulsara, Max; de Boer, W. B.; Jeffrey, Gary P.; MacQuillan, G; Raftopoulos, S; Rossi, E; Speers, David; Western Clinical School: Westmead Millennium Institute; Central Clinical School: PathologyComparison of noninvasive models of fibrosis in chronic hepatitis B, Hepatology International, vol.6, 2, 2012,pp 457-467
2011Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver diseaseGeorge, Jacob; van der Poorten, David; Adams, Leon A.; Bugianesi, Ellisabetta; Bulsara, Max; Ching, Helena L. I.; de Boer, W. B.; Jeffrey, Gary P.; Rossi, Enrico; Western Clinical School: Westmead Institute for Medical Res; Children's Hospital Westmead: MedicineComplex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease, Journal of Gastroenterology and Hepatology, vol.26, 10, 2011,pp 1536-1543
2013Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytesGeorge, Jacob; Grewal, (Ranjit) Thomas; Hoy, Andrew; Iseli, Tristan; Kim, Moon; Roufogalis, Basil; Lee, Kyoung-Tae; Western Clinical School: Westmead Millennium Institute; Pharmacy; School of Medical Sciences: Physiology; Western Clinical School: Medicine (Westmead); Pharmacy; PharmacyCompound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes, Liver International, vol.33, 10, 2013,pp 1583-1593
2012Cost of treating chronic hepatitis B: Comparison of current treatment guidelinesGeorge, Jacob; Robotin, Monica; Kansil, Melanie; Patton, Yumi; Penman, Andrew; Western Clinical School: Westmead Millennium Institute; School of Public Health: Public HealthCost of treating chronic hepatitis B: Comparison of current treatment guidelines, World Journal of Gastroenterology, vol.18, 42, 2012,pp 6106-6113
2009Costs of managing conditions associated with obesity among Australian teenagers.Aitken, Robert; Booth, Michael; Denney-Wilson, Elizabeth; Dobbins, Timothy; George, Jacob; Hardy, Louise; Cowell, Christopher T.; Okely, Anthony D; Sullivan, David; Medicine; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: Public Health; Western Clinical School: Westmead Millennium Institute; School of Public Health: Public HealthCosts of managing conditions associated with obesity among Australian teenagers., Journal of Paediatrics and Child Health, vol.45, 7-8,pp 448-456
2005Current approaches to the diagnosis and management of hepatocellular carcinomaFarrell, Geoffrey; George, Jacob; McCaughan, Geoffrey; Perry, John; Poustchi, Hossein; Strasser, Simone; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary Institute; Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: AW Morrow Gastroenterology and LivCurrent approaches to the diagnosis and management of hepatocellular carcinoma, Clinical and Experimental Medicine, vol.5,(1),2005,pp 1-13
2013Current concepts on the role of nitric oxide in portal hypertensionGeorge, Jacob; Hu, LiangShuo; Wang, Jianhua; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Current concepts on the role of nitric oxide in portal hypertension, World Journal of Gastroenterology, vol.19, 11, 2013,pp 1707-1717
2015Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 InfectionGeorge, Jacob; Strasser, Simone; Dore, GJ; et al, Various; Hezode, Christophe; Lawitz, Eric; Ramji, Alnoor; Shafran, Stephen; Taliani, Gloria; Tatum, Harvey; Tran, Albert; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: MedicineDaclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection, Gastroenterology, vol.148, 2, 2015,pp 355-366
2013Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirinGeorge, Jacob; Andreone, P; Chuang, W; et al, Various; Foster, G; Lee, C; Pianko, S; Piratvisuth, T; Sarin, S; Shah, S; Sood, A; Zeuzem, S; Western Clinical School: Westmead Millennium InstituteDecline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin, Journal of Viral Hepatitis, vol.20, 4, 2013,pp e115-e123